Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2026 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2026 Earnings Call Transcript May 14, 2026

Autolus Therapeutics plc beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.29.

Operator: Good day, everyone, and welcome to Autolus Therapeutics First Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the call over to the Executive Director of Investor Relations, Amanda Cray....